A calendar threshold tells you when gamma risk is accelerating. It doesn't tell you whether the market agrees that now is the moment to actually de-risk. Building the structural read from the R level up, on the Monthly, is how you get that second opinion.
The ProblemTime defines when gamma can start to accelerate. That's mechanical, it's why a DTE threshold belongs in the mandate at all. What time does not define is where price actually is, or what's more likely to happen from there. A calendar trigger can't tell a strike sitting in open air from a strike sitting on top of a major level, because it was never built to look at price in the first place.
The SolutionPriceMap is the delta-1 foundation. It's what defines where price is and what that position actually implies, the piece the calendar was never going to give you. In this article, we're going to build that read from the ground up: start with the R level, add the Critical Range around it, then layer in the minor levels that fill in the picture. From there we'll match the duration to the trade, and show you the position through the lens of the structure that actually governs it.
Picking up where Part 1 left off: Fund B rolled its short call once already, out of the Aug 28 $2,050 strike and into a Sep 25 $2,200 call at 46 DTE. Assume no time has passed since then, same position, same trigger. Delta sits near 0.25, gamma at 0.00096. That's what time told us: this is the moment to look. It doesn't tell us what happens next. Structure does, and that's the layer this piece adds on top of the trigger.
We already know the mechanics from Part 1: theta pays the seller, gamma accelerates on the same clock, that's why the DTE threshold belongs in the mandate. What it can't tell you is anything about price. Time to look through a different lens.
The duration you're reading has to match the trade. A 76 DTE option already runs past what the Monthly meaningfully covers. Start at the Quarterly, step down to the Monthly as DTE shrinks toward the trigger.
R is the sentiment fulcrum, the level that sets the sentiment bias for the duration. R above DIR is negative. R at DIR is neutral. R under DIR is positive.
Layer the Quarterly R onto the Monthly R against current price and the read is consistent at both durations:
Both negative.
R defines the sentiment of the duration, the regime. The Critical Range has a different job: DIR, UP, and DP together define the range for the duration.
On the Monthly, Monthly DP sits at $1,484.03, defining the lower Critical Range pivot. Monthly UP sits at $2,161.53, defining the upper Critical Range pivot. And Monthly DIR sits at $1,806.80, defining the standard price pivot for the session. Price at $1,896.95 sits above DIR, so price bias reads positive even while the R-defined regime reads negative.
If we were to walk through this: looking at the Quarterly, we're over Quarterly DIR. Looking at the Monthly, we're over Monthly DIR. Price bias reads positive on both durations. We also know we're sitting in a negative regime on both. So where can this go? Look up, and the alignment shows up immediately: the R level sits at Monthly UP, which is in alignment with Quarterly UP. That's naturally where we'd be looking for risk.
R and the Critical Range give you the frame. The minor levels fill in the detail inside it. CR+ and CR- are validation levels inside the range, not the zone boundaries themselves, currently Monthly CR+ at $1,984.16 and Monthly CR- at $1,645.41. Beyond those, CRX+ and CRX- mark wider validation levels, $2,330.90 and $1,314.65 respectively.
None of these levels replace R or the Critical Range. They exist to confirm or deny the path to the Critical Range, and can be used as triggers for leaning into or out of risk. Price clearing Monthly CR+ on the way up would add weight to the path toward R. On the downside, Monthly DIR is the level that actually invalidates the positive price bias, price losing Monthly CR- would already be well past that, confirming the breakdown rather than causing it.
This is what the build actually gets you: Quarterly framing the trade at entry, Monthly narrowing the lens as the trigger approaches, stacked on the same price axis, same clock.
One more thing the stacked view makes obvious: Monthly R at $2,161.53 sits almost right on top of Quarterly UP at $2,181.30, about $20 apart. That's where our eyes should be focusing, a Monthly R level and a Quarterly breakout level converging in the same narrow zone.
Price above both DIRs tells us price wants higher. It doesn't tell us when. We do have a cadence, though: this trade goes on at 76 DTE and rolls roughly every 30 days, and the $2,200 strike sits healthily aligned with that monthly cadence, right above Monthly R/UP. That alignment is what's positive about the placement. It's also the risk, the same move higher that confirms the bias is what threatens the strike.
There's no secret solution here. Price is price. Because price is what drives the risk, staying ahead of it early matters more than reacting to it. Price currently supports both the Monthly DIR and the Quarterly DIR, and that alignment is the signal to start moving some risk up now, not waiting for a trigger to force the decision. We can move 1/3 of the risk higher here, based on that support. Monthly CR+ +VAR at $2,010.92 is the trigger for the other 2/3, the bulk of it, moving higher toward Monthly CRX+ at $2,330.90.
What does moving that first 1/3 actually do to portfolio gamma? Pulling live numbers from Navigator: the current $2,200 Sep 25 call carries a gamma of 0.00096 per contract. The nearest listed strike up near CRX+ is $2,300, gamma 0.00071 per contract, lower because it sits further out of the money.
| Strike | Contracts | Gamma / Contract | Portfolio Gamma |
|---|---|---|---|
| $2,200 (current, all 1,000) | 1,000 | 0.00096 | 0.960 |
| $2,200 (remaining 2/3) | 667 | 0.00096 | 0.640 |
| $2,300 (1/3 moved up) | 333 | 0.00071 | 0.237 |
| Blended after the move | 1,000 | — | 0.877 |
Moving 1/3 of the position up from $2,200 to $2,300 takes portfolio gamma from 0.960 to roughly 0.877, an 8.7% reduction, before the CR+ +VAR trigger even fires. That's the piece worth being on top of early: the reduction isn't waiting on a level, it's available right now because price already supports both DIRs.
Time doesn't tell you where you're at risk. It tells you when. Gamma accelerates as expiration nears, that's fundamental, and it's exactly why a DTE threshold belongs in every mandate. But time was never built to say anything about price, and a calendar trigger alone can't tell a strike sitting in open air from one sitting on top of a major level.
PriceMap is the delta-1 foundation that fills that gap. Built from the ground up, R sets the sentiment bias for the duration, the Critical Range defines the range and the pivot inside it, and the minor levels confirm or deny the path. Matched to the right duration and stacked, Quarterly framing the trade at entry, Monthly narrowing the lens as the trigger approaches, the same strike that looked exposed on the calendar alone shows a real trigger ladder: where to lean into risk, where to lean out, and why.
None of this is new. Selling options for yield is one of the most widely used strategies in finance. What changes is having a structural foundation to manage that risk on, instead of managing it on time alone, proactively instead of reactively.
Disclaimer: Pricing and PriceMap data reflect live market conditions at time of writing and will have moved by the time you're reading this. This analysis is for educational purposes only and does not constitute trading advice.